Pharmacotherapy for Breakthrough Cancer Pain
- 1 January 2012
- journal article
- review article
- Published by Springer Nature in Drugs
- Vol. 72 (2) , 181-190
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Single-Dose Pharmacokinetics of Fentanyl Buccal Soluble FilmPain Medicine, 2010
- Efficacy and long-term tolerability of sublingual fentanyl orally disintegrating tablet in the treatment of breakthrough cancer painCurrent Medical Research and Opinion, 2009
- A comparison of intranasal fentanyl spray with oral transmucosal fentanyl citrate for the treatment of breakthrough cancer pain: an open-label, randomised, crossover trialCurrent Medical Research and Opinion, 2009
- Fentanyl buccal tablet for relief of breakthrough pain in opioid-tolerant patients with cancer-related chronic pain.2007
- Oral transmucosal fentanyl citrate in the management of breakthrough pain in cancer: an open, multicentre, dose-titration and long-term use studyPalliative Medicine, 2004
- Episodic (breakthrough) painCancer, 2002
- Breakthrough cancer pain: a randomized trial comparing oral transmucosal fentanyl citrate (OTFC®) and morphine sulfate immediate release (MSIR®)Pain, 2001
- Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration studyPain, 1999
- Oral Transmucosal Fentanyl Citrate: Randomized, Double-Blinded, Placebo-Controlled Trial for Treatment of Breakthrough Pain in Cancer PatientsJNCI: Journal of the National Cancer Institute, 1998
- Breakthrough pain: definition, prevalence and characteristicsPain, 1990